gut
ME
ta
G
enome
A
tlas
Home
Browse
Search
Download
Help
About
Citation
LZX Lab
Introduction
Databases
dbEBV
dbRicePro
gutMEGA
iHypoxia
iCysMod
qPhos
qPTM
Tools
cPhosBac
DeepCalpain
DeepGSH
Deep-PLA
DrugCVar
dSCOPE
pCysMod
prkC-PSP
Result
sample = 'stool'
Search content: Sample = stool
There are 54829 entries with your keyword(s).
Condition
1 month, Asthma / Normal
1 week, Asthma / Normal
1 year, Sensitized / Non-Sensitized
10 days, Intrapartum antimicrobial prophylaxis / Control
10-19 years / 4-9 years
10-19 years / Preweaning
10-19 years / Weaned-3 years
10-19 years / Weaning
12 months, Asthma / Normal
2 days, Intrapartum antimicrobial prophylaxis / Control
20-29 years / 10-19 years
20-29 years / 4-9 years
20-29 years / Preweaning
20-29 years / Weaned-3 years
20-29 years / Weaning
3 months, Sensitized / Non-Sensitized
30 days, Intrapartum antimicrobial prophylaxis / Control
30-39 years / 10-19 years
30-39 years / 20-29 years
30-39 years / 4-9 years
30-39 years / Preweaning
30-39 years / Weaned-3 years
30-39 years / Weaning
4-9 years / Preweaning
4-9 years / Weaned-3 years
4-9 years / Weaning
40-49 years / 10-19 years
40-49 years / 20-29 years
40-49 years / 30-39 years
40-49 years / 4-9 years
40-49 years / Preweaning
40-49 years / Weaned-3 years
40-49 years / Weaning
50-59 years / 10-19 years
50-59 years / 20-29 years
50-59 years / 30-39 years
50-59 years / 4-9 years
50-59 years / 40-49 years
50-59 years / Preweaning
50-59 years / Weaned-3 years
50-59 years / Weaning
60-69 years / 10-19 years
60-69 years / 20-29 years
60-69 years / 30-39 years
60-69 years / 4-9 years
60-69 years / 40-49 years
60-69 years / 50-59 years
60-69 years / Preweaning
60-69 years / Weaned-3 years
60-69 years / Weaning
70-79 years / 10-19 years
70-79 years / 20-29 years
70-79 years / 30-39 years
70-79 years / 4-9 years
70-79 years / 40-49 years
70-79 years / 50-59 years
70-79 years / 60-69 years
70-79 years / Preweaning
70-79 years / Weaned-3 years
70-79 years / Weaning
80-89 years / 10-19 years
80-89 years / 20-29 years
80-89 years / 30-39 years
80-89 years / 4-9 years
80-89 years / 40-49 years
80-89 years / 50-59 years
80-89 years / 60-69 years
80-89 years / 70-79 years
80-89 years / Preweaning
80-89 years / Weaned-3 years
80-89 years / Weaning
90 days, Intrapartum antimicrobial prophylaxis / Control
90-99 years / 10-19 years
90-99 years / 20-29 years
90-99 years / 30-39 years
90-99 years / 4-9 years
90-99 years / 40-49 years
90-99 years / 50-59 years
90-99 years / 60-69 years
90-99 years / 70-79 years
90-99 years / 80-89 years
90-99 years / Preweaning
90-99 years / Weaned-3 years
90-99 years / Weaning
> 100 years / 10-19 years
> 100 years / 20-29 years
> 100 years / 30-39 years
> 100 years / 4-9 years
> 100 years / 40-49 years
> 100 years / 50-59 years
> 100 years / 60-69 years
> 100 years / 70-79 years
> 100 years / 80-89 years
> 100 years / 90-99 years
> 100 years / Preweaning
> 100 years / Weaned-3 years
> 100 years / Weaning
Acne vulgaris patients / Normal
Acute lymphoblastic leukemia, Postconsolidation / Baseline
Acute lymphoblastic leukemia, Postconsolidation / Postinduction
Acute lymphoblastic leukemia, Postinduction / Baseline
Acute lymphoblastic leukemia, Postreinduction / Baseline
Acute lymphoblastic leukemia, Postreinduction / Postconsolidation
Acute lymphoblastic leukemia, Postreinduction / Postinduction
Adult control / Pediatric control
Adults / Breast-fed infants
Advanced colorectal adenoma / Normal
Advanced conventional adenoma / Normal
Alcoholic liver disease / Alcohol dependence syndrome
Amerindians / Malawi
Ampicillin / Control
Amyotrophic lateral sclerosis / Normal
Animal-based diet / Plant-based diet
Anti-islet cell autoantibodies, Developed / Remained negative
Antibiotics, No exposure / Chronic exposure
Any breast-fed children, Mother secretor / Mother non-secretor
Aspirin regimen / Control
Asymptomatic C. difficile carriers / C. difficile infection
Asymptomatic C. difficile carriers / Normal
Atherosclerotic cardiovascular disease / Normal
Atrial fibrillation / No atrial fibrillation
Austria / China
Austria / Denmark
Austria / France
Austria / Malawi
Austria / Peru
Austria / Russia
Austria / Spain
Austria / Sweden
Austria / USA
Austria / Venezuela
Autism / Normal
Autism / Pervasive developmental disorder not otherwise specified
Autistic / Neurotypical
Babies / Adults
Bai / Han
Behcet / Normal
Beta2-1 fructan / Placebo
Bipolar disorder / Normal
Blend of corn/safflower oil / Conventional canola oil
Blend of corn/safflower oil / DHA-enriched high oleic canola oil
Blend of flax/safflower oil / Blend of corn/safflower oil
Blend of flax/safflower oil / Conventional canola oil
Blend of flax/safflower oil / DHA-enriched high oleic canola oil
Blood pressure medication / Control
BMI gain, Follow up / Baseline
BMI loss, Follow up / Baseline
Breast-fed / Placebo formula
Brown rice / Baseline
Brown rice+Whole-grain barley / Baseline
Brown rice+Whole-grain barley / Brown rice
C. difficile infection / Donor
C. difficile infection / Normal
C. difficile infection patient 1, 11 days post-FTM / 3 days post-FTM
C. difficile infection patient 1, 11 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 11 days post-FTM / 7 days post-FTM
C. difficile infection patient 1, 11 days post-FTM / Donor
C. difficile infection patient 1, 128 days post-FTM / 11 days post-FTM
C. difficile infection patient 1, 128 days post-FTM / 18 days post-FTM
C. difficile infection patient 1, 128 days post-FTM / 25 days post-FTM
C. difficile infection patient 1, 128 days post-FTM / 3 days post-FTM
C. difficile infection patient 1, 128 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 128 days post-FTM / 65 days post-FTM
C. difficile infection patient 1, 128 days post-FTM / 7 days post-FTM
C. difficile infection patient 1, 128 days post-FTM / 95 days post-FTM
C. difficile infection patient 1, 128 days post-FTM / Donor
C. difficile infection patient 1, 18 days post-FTM / 11 days post-FTM
C. difficile infection patient 1, 18 days post-FTM / 3 days post-FTM
C. difficile infection patient 1, 18 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 18 days post-FTM / 7 days post-FTM
C. difficile infection patient 1, 18 days post-FTM / Donor
C. difficile infection patient 1, 25 days post-FTM / 11 days post-FTM
C. difficile infection patient 1, 25 days post-FTM / 18 days post-FTM
C. difficile infection patient 1, 25 days post-FTM / 3 days post-FTM
C. difficile infection patient 1, 25 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 25 days post-FTM / 7 days post-FTM
C. difficile infection patient 1, 25 days post-FTM / Donor
C. difficile infection patient 1, 3 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 3 days post-FTM / Donor
C. difficile infection patient 1, 3 days pre-FTM / Donor
C. difficile infection patient 1, 65 days post-FTM / 11 days post-FTM
C. difficile infection patient 1, 65 days post-FTM / 18 days post-FTM
C. difficile infection patient 1, 65 days post-FTM / 25 days post-FTM
C. difficile infection patient 1, 65 days post-FTM / 3 days post-FTM
C. difficile infection patient 1, 65 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 65 days post-FTM / 7 days post-FTM
C. difficile infection patient 1, 65 days post-FTM / Donor
C. difficile infection patient 1, 7 days post-FTM / 3 days post-FTM
C. difficile infection patient 1, 7 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 7 days post-FTM / Donor
C. difficile infection patient 1, 95 days post-FTM / 11 days post-FTM
C. difficile infection patient 1, 95 days post-FTM / 18 days post-FTM
C. difficile infection patient 1, 95 days post-FTM / 25 days post-FTM
C. difficile infection patient 1, 95 days post-FTM / 3 days post-FTM
C. difficile infection patient 1, 95 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 95 days post-FTM / 65 days post-FTM
C. difficile infection patient 1, 95 days post-FTM / 7 days post-FTM
C. difficile infection patient 1, 95 days post-FTM / Donor
C. difficile infection patient 2, 1 days pre-FTM / Donor
C. difficile infection patient 2, 112 days post-FTM / 1 days pre-FTM
C. difficile infection patient 2, 112 days post-FTM / 27 days post-FTM
C. difficile infection patient 2, 112 days post-FTM / 3 days post-FTM
C. difficile infection patient 2, 112 days post-FTM / 41 days post-FTM
C. difficile infection patient 2, 112 days post-FTM / 7 days post-FTM
C. difficile infection patient 2, 112 days post-FTM / 81 days post-FTM
C. difficile infection patient 2, 112 days post-FTM / Donor
C. difficile infection patient 2, 27 days post-FTM / 1 days pre-FTM
C. difficile infection patient 2, 27 days post-FTM / 3 days post-FTM
C. difficile infection patient 2, 27 days post-FTM / 7 days post-FTM
C. difficile infection patient 2, 27 days post-FTM / Donor
C. difficile infection patient 2, 3 days post-FTM / 1 days pre-FTM
C. difficile infection patient 2, 3 days post-FTM / Donor
C. difficile infection patient 2, 41 days post-FTM / 1 days pre-FTM
C. difficile infection patient 2, 41 days post-FTM / 27 days post-FTM
C. difficile infection patient 2, 41 days post-FTM / 3 days post-FTM
C. difficile infection patient 2, 41 days post-FTM / 7 days post-FTM
C. difficile infection patient 2, 41 days post-FTM / Donor
C. difficile infection patient 2, 7 days post-FTM / 1 days pre-FTM
C. difficile infection patient 2, 7 days post-FTM / 3 days post-FTM
C. difficile infection patient 2, 7 days post-FTM / Donor
C. difficile infection patient 2, 81 days post-FTM / 1 days pre-FTM
C. difficile infection patient 2, 81 days post-FTM / 27 days post-FTM
C. difficile infection patient 2, 81 days post-FTM / 3 days post-FTM
C. difficile infection patient 2, 81 days post-FTM / 41 days post-FTM
C. difficile infection patient 2, 81 days post-FTM / 7 days post-FTM
C. difficile infection patient 2, 81 days post-FTM / Donor
C. difficile infection patient 3, 13 days post-FTM / 15 days pre-FTM
C. difficile infection patient 3, 13 days post-FTM / 7 days post-FTM
C. difficile infection patient 3, 13 days post-FTM / Donor
C. difficile infection patient 3, 15 days pre-FTM / Donor
C. difficile infection patient 3, 20 days post-FTM / 13 days post-FTM
C. difficile infection patient 3, 20 days post-FTM / 15 days pre-FTM
C. difficile infection patient 3, 20 days post-FTM / 7 days post-FTM
C. difficile infection patient 3, 20 days post-FTM / Donor
C. difficile infection patient 3, 28 days post-FTM / 13 days post-FTM
C. difficile infection patient 3, 28 days post-FTM / 15 days pre-FTM
C. difficile infection patient 3, 28 days post-FTM / 20 days post-FTM
C. difficile infection patient 3, 28 days post-FTM / 7 days post-FTM
C. difficile infection patient 3, 28 days post-FTM / Donor
C. difficile infection patient 3, 36 days post-FTM / 13 days post-FTM
C. difficile infection patient 3, 36 days post-FTM / 15 days pre-FTM
C. difficile infection patient 3, 36 days post-FTM / 20 days post-FTM
C. difficile infection patient 3, 36 days post-FTM / 28 days post-FTM
C. difficile infection patient 3, 36 days post-FTM / 7 days post-FTM
C. difficile infection patient 3, 36 days post-FTM / Donor
C. difficile infection patient 3, 68 days post-FTM / 13 days post-FTM
C. difficile infection patient 3, 68 days post-FTM / 15 days pre-FTM
C. difficile infection patient 3, 68 days post-FTM / 20 days post-FTM
C. difficile infection patient 3, 68 days post-FTM / 28 days post-FTM
C. difficile infection patient 3, 68 days post-FTM / 36 days post-FTM
C. difficile infection patient 3, 68 days post-FTM / 7 days post-FTM
C. difficile infection patient 3, 68 days post-FTM / Donor
C. difficile infection patient 3, 7 days post-FTM / 15 days pre-FTM
C. difficile infection patient 3, 7 days post-FTM / Donor
C. difficile infection patient 3, 90 days post-FTM / 13 days post-FTM
C. difficile infection patient 3, 90 days post-FTM / 15 days pre-FTM
C. difficile infection patient 3, 90 days post-FTM / 20 days post-FTM
C. difficile infection patient 3, 90 days post-FTM / 28 days post-FTM
C. difficile infection patient 3, 90 days post-FTM / 36 days post-FTM
C. difficile infection patient 3, 90 days post-FTM / 68 days post-FTM
C. difficile infection patient 3, 90 days post-FTM / 7 days post-FTM
C. difficile infection patient 3, 90 days post-FTM / Donor
C. difficile infection, Recurrent / Nonrecurrent
C. difficile infection, Reinfection / Nonrecurrent
Caesarean section, Full-term / Pre-term
Children with PZQ, 1.1-2 years / 0-1 years
Children with PZQ, 10.1-13 years / 0-1 years
Children with PZQ, 10.1-13 years / 1.1-2 years
Children with PZQ, 10.1-13 years / 2.1-3 years
Children with PZQ, 10.1-13 years / 3.1-4 years
Children with PZQ, 10.1-13 years / 4.1-5 years
Children with PZQ, 10.1-13 years / 5.1-6 years
Children with PZQ, 10.1-13 years / 6.1-7 years
Children with PZQ, 10.1-13 years / 7.1-8 years
Children with PZQ, 10.1-13 years / 8.1-9 years
Children with PZQ, 10.1-13 years / 9.1-10 years
Children with PZQ, 2.1-3 years / 0-1 years
Children with PZQ, 2.1-3 years / 1.1-2 years
Children with PZQ, 3.1-4 years / 0-1 years
Children with PZQ, 3.1-4 years / 1.1-2 years
Children with PZQ, 3.1-4 years / 2.1-3 years
Children with PZQ, 4.1-5 years / 0-1 years
Children with PZQ, 4.1-5 years / 1.1-2 years
Children with PZQ, 4.1-5 years / 2.1-3 years
Children with PZQ, 4.1-5 years / 3.1-4 years
Children with PZQ, 5.1-6 years / 0-1 years
Children with PZQ, 5.1-6 years / 1.1-2 years
Children with PZQ, 5.1-6 years / 2.1-3 years
Children with PZQ, 5.1-6 years / 3.1-4 years
Children with PZQ, 5.1-6 years / 4.1-5 years
Children with PZQ, 6.1-7 years / 0-1 years
Children with PZQ, 6.1-7 years / 1.1-2 years
Children with PZQ, 6.1-7 years / 2.1-3 years
Children with PZQ, 6.1-7 years / 3.1-4 years
Children with PZQ, 6.1-7 years / 4.1-5 years
Children with PZQ, 6.1-7 years / 5.1-6 years
Children with PZQ, 7.1-8 years / 0-1 years
Children with PZQ, 7.1-8 years / 1.1-2 years
Children with PZQ, 7.1-8 years / 2.1-3 years
Children with PZQ, 7.1-8 years / 3.1-4 years
Children with PZQ, 7.1-8 years / 4.1-5 years
Children with PZQ, 7.1-8 years / 5.1-6 years
Children with PZQ, 7.1-8 years / 6.1-7 years
Children with PZQ, 8.1-9 years / 0-1 years
Children with PZQ, 8.1-9 years / 1.1-2 years
Children with PZQ, 8.1-9 years / 2.1-3 years
Children with PZQ, 8.1-9 years / 3.1-4 years
Children with PZQ, 8.1-9 years / 4.1-5 years
Children with PZQ, 8.1-9 years / 5.1-6 years
Children with PZQ, 8.1-9 years / 6.1-7 years
Children with PZQ, 8.1-9 years / 7.1-8 years
Children with PZQ, 9.1-10 years / 0-1 years
Children with PZQ, 9.1-10 years / 1.1-2 years
Children with PZQ, 9.1-10 years / 2.1-3 years
Children with PZQ, 9.1-10 years / 3.1-4 years
Children with PZQ, 9.1-10 years / 4.1-5 years
Children with PZQ, 9.1-10 years / 5.1-6 years
Children with PZQ, 9.1-10 years / 6.1-7 years
Children with PZQ, 9.1-10 years / 7.1-8 years
Children with PZQ, 9.1-10 years / 8.1-9 years
Children, Mother secretor / Mother non-secretor
Children, Secretor / Non-secretor
China / Korea
China / Malawi
China / Peru
China / USA
China / Venezuela
China, After 2 weeks / Baseline
China, Urban / Rural
Chinese / Orang Asli
Chinese Han living in Shaanxi province / Tibetans
Chinese Han living in Tibet / Chinese Han living in Shaanxi province
Chinese Han living in Tibet / Tibetans
Chloramphenicol / Control
Chronic periodontitis / Gingivitis
Chronic periodontitis / Periodontal health
Chubu / Hokkaido
Chubu / Kanto
Chubu / Tohoku
Chugoku Shikoku / Chubu
Chugoku Shikoku / Hokkaido
Chugoku Shikoku / Kansai
Chugoku Shikoku / Kanto
Chugoku Shikoku / Tohoku
Ciprofloxacin / Control
Clostridia phase / Bacilli phase
Clostridia phase / Gammaproteobacteria phase
Collected in the inner / Collected in the outer
Colon polyps / Normal
Colorectal adenoma / Normal
Colorectal cancer / Colorectal adenoma
Colorectal cancer / Normal
Constipated / Normal
Constipated after lubiprostone / Normal
Constipated before lubiprostone / Normal
Constipation / Normal
Conventional adenoma / Normal
Coronary artery disease / Normal
Crohn's disease / Normal
Crohn's disease / Ulcerative colitis
Crohn's disease Active / Normal
Crohn's disease active onset / Normal
Crohn's disease Active presurgery / Normal
Crohn's disease in colon / Normal
Crohn's disease in ileum / Normal
Crohn's disease, Active / Active onset
Crohn's disease, Active presurgery / Active
Crohn's disease, Active presurgery / Active onset
Cystic fibrosis / Normal
Day Hospital / Community
Denmark / China
Denmark / Malawi
Denmark / Peru
Denmark / USA
Denmark / Venezuela
DHA-enriched high oleic canola oil / Conventional canola oil
Diarrheal Phase 2 / Diarrheal Phase 1
Diarrheal Phase 3 / Diarrheal Phase 1
Diarrheal Phase 4 / Diarrheal Phase 1
Digitoxin / Control
Digoxin / Control
Distal conventional adenoma / Normal
Doxycycline / Control
During the first ciprofloxacin course / Before ciprofloxacin
During the first week post-first ciprofloxacin / Before ciprofloxacin
During the first week post-second ciprofloxacin / Before ciprofloxacin
During the second ciprofloxacin course / Before ciprofloxacin
Dysbiotic / Nondysbiotic
Erythromycin / Control
Exclusively breast-fed children, Mother secretor / Mother non-secretor
Flatulence / Normal
Formula-fed / Breast-fed
Formula-fed infants / Breast-fed infants
France / China
France / Denmark
France / Malawi
France / Peru
France / Russia
France / Spain
France / Sweden
France / USA
France / Venezuela
Full-term, Caesarean section / Spontaneous vaginally delivered
Gammaproteobacteria phase / Bacilli phase
Gestational diabetes mellitus / Normal
Gingivitis / Periodontal health
Habitual diet+Resistant starch / Habitual diet
Hashimoto's thyroiditis / Normal
Healthy control-like irritable bowel syndrome / Normal
Hepatic encephalopathy / Normal
High gene count / Low gene count
High oleic canola oil / Conventional canola oil
High oleic canola oil / DHA-enriched high oleic canola oil
Hirschsprung disease / Hirschsprung-associated enterocolitis
HIV / Normal
HIV negative, Men sex with men / Men sex with women
HIV+Non-nucleoside reverse transcriptase inhibitors / Normal
HIV+Ritonavir-boosted protease inhibitors / Normal
HIV, CD4 > 200 / CD4 < 200
HIV, Men sex with men / Non-men sex with men
HIV, Negative / CD4 < 200
HIV, Ritonavir-boosted protease inhibitors / Non-nucleoside reverse transcriptase inhibitors
Hodgkin lymphoma / Normal
Homogenised / Collected in the outer
Hookworm infection, 8 weeks after / Prior
Human Microbiome Project healthy samples / Korean adolescent healthy samples
Human Microbiome Project participants / Korean twins
Hyperplastic polyp / Normal
Idiopathic rapid eye movement sleep behavior disorder / Normal
Idiopathic rapid eye movement sleep behavior disorder / Parkinson's disease
In the interim period between ciprofloxacin courses / Before ciprofloxacin
Infant 1 month / Mother 1 week prior to delivery
Infant 1 week / Mother 1 week prior to delivery
Infant 1 year / Mother 1 week prior to delivery
Infant 3 months / Mother 1 week prior to delivery
Infant 7 months / Mother 1 week prior to delivery
Infant with HLA-DQ2 / Infant without HLA-DQ2/8
Infants 1 month, IgE-eczema / Control
Infants 1 week, IgE-eczema / Control
Infants 1 year breastfeeding, 3 months exclusive / 3 months none
Infants 1 year breastfeeding, 3 months exclusive / 3 months partial
Infants 1 year breastfeeding, 3 months partial / 3 months none
Infants 1 year breastfeeding, 6 months exclusive / 3 months exclusive
Infants 1 year breastfeeding, 6 months exclusive / 3 months none
Infants 1 year breastfeeding, 6 months exclusive / 3 months partial
Infants 1 year breastfeeding, 6 months exclusive / 6 months none
Infants 1 year breastfeeding, 6 months exclusive / 6 months partial
Infants 1 year breastfeeding, 6 months none / 3 months exclusive
Infants 1 year breastfeeding, 6 months none / 3 months none
Infants 1 year breastfeeding, 6 months none / 3 months partial
Infants 1 year breastfeeding, 6 months partial / 3 months exclusive
Infants 1 year breastfeeding, 6 months partial / 3 months none
Infants 1 year breastfeeding, 6 months partial / 3 months partial
Infants 1 year breastfeeding, 6 months partial / 6 months none
Infants 1 year breastfeeding, 6-12 months / 3 months exclusive
Infants 1 year breastfeeding, 6-12 months / 3 months none
Infants 1 year breastfeeding, 6-12 months / 3 months partial
Infants 1 year breastfeeding, 6-12 months / 6 months exclusive
Infants 1 year breastfeeding, 6-12 months / 6 months none
Infants 1 year breastfeeding, 6-12 months / 6 months partial
Infants 1 year breastfeeding, 6-12 months / < 6 months
Infants 1 year breastfeeding, < 6 months / 3 months exclusive
Infants 1 year breastfeeding, < 6 months / 3 months none
Infants 1 year breastfeeding, < 6 months / 3 months partial
Infants 1 year breastfeeding, < 6 months / 6 months exclusive
Infants 1 year breastfeeding, < 6 months / 6 months none
Infants 1 year breastfeeding, < 6 months / 6 months partial
Infants 1 year breastfeeding, > 12 months / 3 months exclusive
Infants 1 year breastfeeding, > 12 months / 3 months none
Infants 1 year breastfeeding, > 12 months / 3 months partial
Infants 1 year breastfeeding, > 12 months / 6 months exclusive
Infants 1 year breastfeeding, > 12 months / 6 months none
Infants 1 year breastfeeding, > 12 months / 6 months partial
Infants 1 year breastfeeding, > 12 months / 6-12 months
Infants 1 year breastfeeding, > 12 months / < 6 months
Infants 1 year intrapartum antibiotic prophylaxis, Elective caesarean section / No vaginal
Infants 1 year intrapartum antibiotic prophylaxis, Elective caesarean section / Vaginal
Infants 1 year intrapartum antibiotic prophylaxis, Emergency caesarean section / Elective caesarean section
Infants 1 year intrapartum antibiotic prophylaxis, Emergency caesarean section / No vaginal
Infants 1 year intrapartum antibiotic prophylaxis, Emergency caesarean section / Vaginal
Infants 1 year intrapartum antibiotic prophylaxis, Vaginal / No vaginal
Infants 12 months, IgE-eczema / Control
Infants 2 months, Anthroposophic / Non-anthroposophic
Infants 3 months breastfeeding, 3 months exclusive / 3 months none
Infants 3 months breastfeeding, 3 months exclusive / 3 months partial
Infants 3 months breastfeeding, 3 months partial / 3 months none
Infants 3 months intrapartum antibiotic prophylaxis, Elective caesarean section / No vaginal
Infants 3 months intrapartum antibiotic prophylaxis, Elective caesarean section / Vaginal
Infants 3 months intrapartum antibiotic prophylaxis, Emergency caesarean section / Elective caesarean section
Infants 3 months intrapartum antibiotic prophylaxis, Emergency caesarean section / No vaginal
Infants 3 months intrapartum antibiotic prophylaxis, Emergency caesarean section / Vaginal
Infants 3 months intrapartum antibiotic prophylaxis, Vaginal / No vaginal
Infants 3 weeks, Anthroposophic / Non-anthroposophic
Infants 6 days, Anthroposophic / Non-anthroposophic
Infants 6 months, Anthroposophic / Non-anthroposophic
Infants, 1 week / 4 weeks
Infants, 4 weeks / 8 weeks
Infants, 8 weeks / 24 weeks
Inflammatory bowel disease / Normal
Inflammatory bowel disease / Pediatric normal
Ingestion of flaxseeds, 1 week post-intervention / Start
Ingestion of flaxseeds, Immediately after intervention / Start
Inpatient / Pediatric control
Intervention formula / Placebo formula
Intrapartum antibiotic prophylaxis / Control
Irritable bowel syndrome / Healthy control-like irritable bowel syndrome
Irritable bowel syndrome / Normal
Irritable bowel syndrome, After treatment / Before treatment
Irritable bowel syndrome-constipation / Normal
Irritable bowel syndrome-diarrhea / Normal
Japan / Austria
Japan / China
Japan / Denmark
Japan / France
Japan / Korea
Japan / Malawi
Japan / Peru
Japan / Russia
Japan / Spain
Japan / Sweden
Japan / USA
Japan / Venezuela
Juvenile idiopathic arthritis / Normal
Kanamycin / Control
Kansai / Chubu
Kansai / Hokkaido
Kansai / Kanto
Kansai / Tohoku
Kanto / Hokkaido
Kanto / Tohoku
Kazakh / Bai
Kazakh / Han
Kazakh / Zhuang
Kazaks diabetes mellitus type 2 / Kazaks normal glucose tolerant
Kyushu / Chubu
Kyushu / Chugoku Shikoku
Kyushu / Hokkaido
Kyushu / Kansai
Kyushu / Kanto
Kyushu / Tohoku
Lactobacillus casei Zhang, 28 days / 0 day
Lactobacillus casei Zhang, 42 days / 0 day
Lactobacillus casei Zhang, 42 days / 28 days
Lactobacillus plantarum P-8, 28 days / 0 day
Levofloxacin, After / Before
Long-stay / Community
Long-stay / Day Hospital
Long-stay / Rehabilitation
Longevity village communities 40-69 year / Urbanized town communities 40-69 year
Longevity village communities 40-69 year / Urbanized town communities Children
Longevity village communities > 70 year / Longevity village communities 40-69 year
Longevity village communities > 70 year / Urbanized town communities 40-69 year
Longevity village communities > 70 year / Urbanized town communities Children
Low birth weight and persistent stunting / Normal
Madagascar / Central African Republic
Major depression disorder visit 1 / Normal
Major depression disorder visit 2 / Normal
Major depression disorder visit 3 / Normal
Major depression disorder, Visit 2 / Visit 1
Major depression disorder, Visit 3 / Visit 1
Major depression disorder, Visit 3 / Visit 2
Malays / Orang Asli
Male / Female
Matses / Norman
Men sex with men, HIV positive+Anti-retroviral therapy / HIV negative
Men sex with men, HIV positive+Anti-retroviral therapy untreated / HIV negative
Moderate to severe diarrhea / Normal
Mongol / Bai
Mongol / Han
Mongol / Kazakh
Mongol / Uyghur
Mongol / Zhuang
Monozygotic twin TS29 / Monozygotic twin TS28
Mother 1 year after delivery / Mother 1 week prior to delivery
Mothers After birth, Anthroposophic / Non-anthroposophic
Mothers Before birth, Anthroposophic / Non-anthroposophic
Mothers, IgE-eczema / Control
Multiple kidney stones / Normal
Multiple sclerosis / Crohn's disease
Multiple sclerosis / Normal
Multiple sclerosis / Ulcerative colitis
Multiple sclerosis treated / Normal
Multiple sclerosis untreated / Normal
Necrotising enterocolitis, Propidium monoazide / Control
Necrotizing enterocolitis / Normal
Neurotypical / Autism spectrum disorder
Nizatidine / Control
No crackers / Native starch
Non-advanced conventional adenoma / Normal
Non-alcoholic fatty liver disease / Normal
Non-alcoholic fatty liver disease, 0-1 fibrosis / > 1 fibrosis
Nonalcoholic steatohepatitis / Normal
Nonalcoholic steatohepatitis / Obese
Nonsteroidal antiinflammatory drug / Control
Norfloxacin / Control
Norovirus infection / Control
Obese / Normal
Obese patients underwent Roux-en-Y gastric bypass, 1 year / Baseline
Obese patients underwent Roux-en-Y gastric bypass, 3 months / Baseline
Other colorectal conditions / Colorectal adenoma
Other colorectal conditions / Normal
Outpatient / Pediatric control
Pancreaticoduodenectomy / American Gut Project
Parkinson's disease / Normal
Past azithromycin 0 day / Normal
Past azithromycin 1 day / Normal
Past azithromycin 1 month / Normal
Past azithromycin 1 week / Normal
Past azithromycin, 1 day / 0 day
Past azithromycin, 1 month / 0 day
Past azithromycin, 1 month / 1 day
Past azithromycin, 1 month / 1 week
Past azithromycin, 1 week / 0 day
Past azithromycin, 1 week / 1 day
Peru / Malawi
Peru / Venezuela
Pervasive developmental disorder not otherwise specified / Normal
pH4 / pH7
pH5 / pH7
Phenacetin / Control
Phenylketonuria / Normal
Polydextrose / No supplemental fiber
Post ciprofloxacin / Before ciprofloxacin
Post-exclusive enteral nutrition / Pre-exclusive enteral nutrition
Postmenopausal breast cancer / Normal
Postural instability and gait difficulty / Tremor dominant
Pre-term, Caesarean section / Spontaneous vaginally delivered
Premenopausal breast cancer / Normal
Previous TIA/ischemic stroke / No previous TIA/ischemic stroke
Probiotic administration 4 weeks / Baseline
Probiotic intervention / Control
Probiotic, After / Before
Probiotics / Placebo
Proton pump inhibitors, After / Before
Proton pump inhibitors, After / On
Proton pump inhibitors, On / Before
Proximal conventional adenoma / Normal
Recovery Phase 2 / Recovery Phase 1
Recovery Phase 3 / Recovery Phase 1
Rehabilitation / Community
Rehabilitation / Day Hospital
Resistant starch types 2 / Native starch
Resistant starch types 2 / No crackers
Resistant starch types 4 / Native starch
Resistant starch types 4 / No crackers
Resistant starch types 4 / Resistant starch types 2
Rett syndrome / Normal
Rheumatoid arthritis / Crohn's disease
Rheumatoid arthritis / Multiple sclerosis
Rheumatoid arthritis / Normal
Rheumatoid arthritis / Ulcerative colitis
Russia / China
Russia / Denmark
Russia / Malawi
Russia / Peru
Russia / Spain
Russia / USA
Russia / Venezuela
Schistosomiasis, Positive / Negative
Sessile serrated adenoma / Normal
Severely stunted / Moderately stunted
Shiga Toxin-producing E. coli diseased patients / Normal
Shiga Toxin-producing E. coli recovered patients / Normal
Soluble corn fiber / No supplemental fiber
Soluble corn fiber / Polydextrose
Spain / China
Spain / Denmark
Spain / Malawi
Spain / Peru
Spain / USA
Spain / Venezuela
Spontaneous vaginally delivered, Full-term / Pre-term
Statins / Control
Stopping the probiotic intake 4 weeks / Probiotic administration 4 weeks
Stunted / Nonstunted
Subsequent months / First month post-partum
Sulfasalazine / Control
Summer / Winter
SunGold kiwifruit, 12 weeks / Baseline
SunGold kiwifruit, 6 weeks / Baseline
Sweden / China
Sweden / Denmark
Sweden / Malawi
Sweden / Peru
Sweden / Russia
Sweden / Spain
Sweden / USA
Sweden / Venezuela
Tacrolimus, Dose escalation / Dose stable
Tetracycline / Control
Tetramisole / Control
Thyroid carcinoma / Normal
Tibetan / Bai
Tibetan / Han
Tibetan / Kazakh
Tibetan / Mongol
Tibetan / Uyghur
Tibetan / Zhuang
Tohoku / Hokkaido
Trial prior to hookworm infection / Normal
Tunapuco / Matses
Tunapuco / Norman
TUW / Khentii
Type 1 diabetes / Normal
Type 1 diabetes after 2 years treatment / Normal
Type 1 diabetes after 2 years treatment / Type 1 diabetes at onset
Type 1 diabetes at onset / Normal
Type 2 diabetes / Normal
Type 2 diabetes / Normal glucose tolerance
Type 2 diabetes, HbA1c > 47 mmol/mol / HbA1c < 47 mmol/mol
Type 2 diabetes, Metformin / Control
Ulan Bator / Khentii
Ulan Bator / TUW
Ulcerative colitis / Crohn's disease
Ulcerative colitis / Normal
Ulcerative colitis with FMT / Donor
Urban / Rural
Urban Mongolian / Rural Mongolian
Urbanized town communities 40-69 year / Urbanized town communities Children
USA / Amerindians
USA / China
USA / Korea
USA / Malawi
USA / Peru
USA / Venezuela
UTI patients, Adult household / Control
UTI patients, Ciprofloxacin / Control
UTI patients, Fosfomycin / Control
UTI patients, Nitrofurantoin / Control
Uyghur / Bai
Uyghur / Han
Uyghur / Kazakh
Uyghur / Zhuang
Venezuela / Malawi
Weaned-3 years / Preweaning
Weaned-3 years / Weaning
Weaning / Preweaning
Whole-grain barley / Baseline
Whole-grain barley / Brown rice
Whole-grain barley / Brown rice+Whole-grain barley
Women with previous gestational diabetes / Normal
Zhuang / Bai
Zhuang / Han
Zonulin < 46.4 ng/mL / Zonulin > 46.4 ng/mL
Taxon level
Class
Family
Genus
Kingdom
No rank
Order
Phylum
Species
Log2Ratio
>
=
<
Filter
Download
Detail
Taxon
Condition
Log2Ratio
P
value
k__Archaea; p__Euryarchaeota; c__Methanobacteria; o__Methanobacteriales; f__Methanobacteriaceae; g__Methanobrevibacter
High gene count / Low gene count
8.399
<0.001
Loading...
k__Archaea; p__Euryarchaeota; c__Methanobacteria; o__Methanobacteriales; f__Methanobacteriaceae; g__Methanobrevibacter
HIV, Negative / CD4 < 200
3.790311641
<0.001
Loading...
k__Archaea; p__Euryarchaeota; c__Methanobacteria; o__Methanobacteriales; f__Methanobacteriaceae; g__Methanobrevibacter
Probiotic, After / Before
-3.87502
<0.001
Loading...
k__Bacteria
Ampicillin / Control
2.331991778
<0.001
Loading...
k__Bacteria
Asymptomatic C. difficile carriers / Normal
-0.96
<0.001
Loading...
k__Bacteria
Chloramphenicol / Control
1.578214165
<0.001
Loading...
k__Bacteria
Ciprofloxacin / Control
2.075532631
<0.001
Loading...
k__Bacteria
Digitoxin / Control
2.401630467
<0.001
Loading...
k__Bacteria
Digoxin / Control
1.756169328
<0.001
Loading...
k__Bacteria
Doxycycline / Control
3.710723795
<0.001
Loading...
Showing 1 to 10 of 54829 entries
,
10
20
50
100
entries per page
<
1
2
3
4
5
...
5483
>
